Goldman Sachs · 3 months ago
Global Investment Research, Equity Research, Emerging Biotech Associate
San Francisco, California, United States
Full-time
Onsite
Entry Level
$150K/yr - $225K/yr
2+ years expGoldman Sachs is a leading global investment banking, securities and investment management firm. The Associate will work closely with the Senior Analyst and the Biotechnology team to build industry knowledge, generate investment ideas, write reports, and perform data analysis in the biotech sector.
BankingFinanceFinancial ServicesVenture Capital
Responsibilities
Build strong industry knowledge of the biotech sector
Contribute to the generation and execution of investment ideas
Write reports/notes on companies under coverage
Communicate with the equities sales force and traders, clients and company managements
Interpret data and perform analysis on market, economic and technology trends
Develop financial models
Qualification
Required
PhD, MD, MS, or other advanced life sciences degree
Excellent analytical skills
2+ years of experience in investment research, financial modelling and analysis
Strong verbal and written communication skills
Proficiency in Excel
Attention to detail
Strong team orientation
Preferred
Equity research experience
Experience in the Biotech Industry
Working knowledge of accounting, finance, and valuation
Demonstrated interest or previous experience in the biotech sector
Ability to work in a fast-paced, high-energy environment
Comfortable taking initiative and being resourceful/entrepreneurial
Ability to multi-task and work with numerous teams
Benefits
Goldman Sachs is committed to providing our people with valuable and competitive benefits and wellness offerings, as it is a core part of providing a strong overall employee experience.
Company
Goldman Sachs
Goldman Sachs is a multinational financial services firm providing securities, investment banking, and management services.
10001+ employees
H1B Sponsorship
Goldman Sachs has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1954)
2024 (1685)
2023 (2060)
2022 (2326)
2021 (2258)
2020 (1572)
Funding
Current Stage
Public CompanyTotal Funding
$6B2025-04-23Post Ipo Debt· $6B
2012-06-05Post Ipo Equity
1999-05-14IPO
Leadership Team
David M. Solomon
Chair and Chief Executive Officer
John Waldron
President and Chief Operating Officer
Recent News
2026-01-09
BATimes Newspaper
2026-01-08
2026-01-08
Company data provided by crunchbase